Dr Reddys Laboratories
BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
News on Dr Reddys Laboratories
Dr Reddy's to launch 20 products in US in FY20
10.23 pm | 17 May 2019 | Source: Moneycontrol.com
The company anticipates US FDA approval for generic Nuvaring in the first half of FY20, while the launch of generic Copaxone in the US may get further...
Dr Reddy's launches skin treatment drug in US
2.40 pm | 15 May 2019 | Source: PTI
The company has launched its product, which is generic version of Merck Sharp & Dohme Corp's Cubicin, after obtaining approval from the US Food an...
Dr Reddy's acquires a portfolio of 42 ANDAs in US
8.39 am | 14 Apr 2019 | Source: Moneycontrol.com
The acquisition is in line with our stated strategy to significantly enhance our portfolio in our chosen growth markets, Dr Reddy's Laboratories C...
Quick Links for Dr Reddys Laboratories
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.